{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:14:26Z","timestamp":1792530866320,"version":"4.5.0"},"reference-count":101,"publisher":"IMR Press","issue":"4","license":[{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Chronic kidney disease is a growing public health problem, as its prevalence and incidence have almost doubled over the last three decades. Chronic kidney disease is defined as the presence of an estimated glomerular filtration rate &lt; 60 ml\/min\/1.73 m2 and\/or proteinuria \u2265 0.150 g\/24 h. It has been demonstrated that both proteinuria and reduction in estimated glomerular filtration rate can predict the development of fatal and non-fatal cardiovascular events, regardless of traditional cardiovascular risk factors, namely blood pressure, smoking habit, cholesterol, age, gender. This relationship is found in the general population, high-risk cohorts and in patients referred to Nephrologists (tertiary care). The accuracy by which proteinuria or estimated glomerular filtration rate can predict these events, exceeds that obtained by the combination of all the other traditional risk factors. These important findings have led to chronic kidney disease being considered as a cardiovascular risk equivalent. Although this needs further investigation, a great effort has been made to reduce the cardiovascular risk in chronic kidney disease patients. Indeed, many clinical trials have been carried-out testing the effect of antihypertensive, proteinuria-lowering, lipid-lowering and hypoglycemic agents on cardiovascular risk protection. All these trials reduced, but did not eliminate, the overall cardiovascular risk. Future studies should be undertaken to identify high cardiovascular risk patients and novel therapeutic targets for cardiovascular protection in chronic kidney disease patients.<\/jats:p>","DOI":"10.31083\/j.rcm.2019.04.548","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T01:36:22Z","timestamp":1578879382000},"source":"Crossref","is-referenced-by-count":107,"title":["Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer"],"prefix":"10.31083","volume":"20","author":[{"given":"Michele","family":"Provenzano","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Renal Unit, \"Magna Graecia\" University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Coppolino","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Renal Unit, \"Magna Graecia\" University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Faga","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Renal Unit, \"Magna Graecia\" University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Garofalo","sequence":"first","affiliation":[{"name":"Department of Scienze Mediche e Chirurgiche Avanzate, Renal Unit, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Serra","sequence":"first","affiliation":[{"name":"Interuniversity Center of Phlebolymphology (CIFL), \u201cMagna Graecia\u201d University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Andreucci","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Renal Unit, \"Magna Graecia\" University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Adams, K. F. Jr., Fonarow, G. C., Emerman, C. L., LeJemtel, T. H., Costanzo, M. R., Abraham, W. T., Berkowitz, R. L., Galvao, M., Horton, D. P. and Adhere Scientific Advisory Committee Investigators. (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). American Heart Journal 149, 209-216.","DOI":"10.1016\/j.ahj.2004.08.00515846257dc1e6e9f-0362-468d-8087-e5dd8a288574https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15846257"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Anand, I. S., Bishu, K., Rector, T. S., Ishani, A., Kuskowski, M. A. and Cohn, J. N. (2009) Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Circulation 120, 1577-1584.","DOI":"10.1161\/CIRCULATIONAHA.109.85364819805651https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19805651"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Arora, P., Vasa, P., Brenner, D., Iglar, K., McFarlane, P., Morrison, H. and Badawi, A. (2013) Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. Canadian Medical Association Journal 185, E417-E423.","DOI":"10.1503\/cmaj.120833f496e2ab-cb43-43ca-aff6-39133f3e3984http:\/\/dx.doi.org\/10.1503\/cmaj.120833"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Asselbergs, F. W., Diercks, G. F., Hillege, H. L., van Boven, A. J., Janssen, W. M., Voors, A. A., de Zeeuw, D., de Jong, P. E., van Veldhuisen, D. J., van Gilst, W. H. and Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. (2004) Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 110, 2809-2816.","DOI":"10.1161\/01.CIR.0000146378.65439.7A15492322https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15492322"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., Neal, B., Jiang, L., Hooi, L. S., Levin, A., Agodoa, L., Gaziano, M., Kasiske, B., Walker, R., Massy, Z. A., Feldt-Rasmussen, B., Krairittichai, U., Ophascharoensuk, V., Fellstrom, B., Holdaas, H., Tesar, V., Wiecek, A., Grobbee, D., de Zeeuw, D., Gronhagen-Riska, C., Dasgupta, T., Lewis, D., Herrington, W., Mafham, M., Majoni, W., Wallendszus, K., Grimm, R., Pedersen, T., Tobert, J., Armitage, J., Baxter, A., Bray, C., Chen, Y., Chen, Z., Hill, M., Knott, C., Parish, S., Simpson, D., Sleight, P., Young, A., Collins, R., and Sharp Investigators. (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. The Lancet 377, 2181-2192.","DOI":"10.1016\/S0140-6736(11)60739-321663949https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21663949"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Ballew, S. H. and Matsushita, K. (2018) Cardiovascular Risk Prediction in CKD. Seminars in Nephrology 38, 208-216.","DOI":"10.1016\/j.semnephrol.2018.02.00229753398https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29753398"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Berl, T., Hunsicker, L. G., Lewis, J. B., Pfeffer, M. A., Porush, J. G., Rouleau, J. L., Drury, P. L., Esmatjes, E., Hricik, D., Parikh, C. R., Raz, I., Vanhille, P., Wiegmann, T. B., Wolfe, B. M., Locatelli, F., Goldhaber, S. Z., Lewis, E. J. and Group Irbesartan Diabetic Nephropathy Trial. Collaborative Study. (2003) Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Annals of Internal Medicine 138, 542-549.","DOI":"10.7326\/0003-4819-138-7-200304010-0001012667024https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12667024"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Bolignano, D., Coppolino, G., Aloisi, C., Romeo, A., Nicocia, G., and Buemi, M. (2008) Effect of a single intravenous immunoglobulin infusion on neutrophil gelatinase-associated lipocalin levels in proteinuric patients with normal renal function. Journal of Investigative Medicine 56, 997-1003.","DOI":"10.2310\/JIM.0b013e31818e7e9518955901https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18955901"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Bolignano, D., Coppolino, G., Romeo, A., Lacquaniti, A., and Buemi, M. (2010) Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. Nephrology (Carlton) 15, 23-26.","DOI":"10.1111\/j.1440-1797.2009.01163.x20377767https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20377767"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Bolignano, D., D'Arrigo, G., Pisano, A., and Coppolino, G. (2015) Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. PLoS One 10, e0134104.","DOI":"10.1371\/journal.pone.013410426237421https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26237421"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Bolignano, D., Pisano, A., and Coppolino, G. (2016) The Dark Side of Blocking RAS in Diabetic Patients with Incipient or Manifested Nephropathy. Experimental and Clinical Endocrinology & Diabetes 124, 350-360.","DOI":"10.2215\/CJN.0606051931831576https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31831576"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Brugts, J. J., Boersma, E., Chonchol, M., Deckers, J. W., Bertrand, M., Remme, W. J., Ferrari, R., Fox, K., Simoons, M. L., and Europa, Investigators. (2007) The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial. Journal of the American College of Cardiology 50, 2148-2155.","DOI":"10.1016\/j.jacc.2007.08.029958f44d6-7edc-4028-b32f-afa871621015http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0735109707028793"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Buemi, M., Senatore, M., Gallo, G. C., Crasci, E., Campo, S., Sturiale, A., Coppolino, G., Bolignano, D., and Frisina, N. (2007) Pulmonary hypertension and erythropoietin. Kidney and Blood Pressure Research 30, 248-252.","DOI":"10.1159\/00010444317587864https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17587864"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Cedillo-Couvert, E., and Ricardo, A. C. (2016) Smoking, Vascular Events, and ESRD in Patients With CKD. American Journal of Kidney Diseases 68 , 338-340.","DOI":"10.1053\/j.ajkd.2016.06.00427561666https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27561666"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Cheung, A. K., Rahman, M., Reboussin, D. M., Craven, T. E., Greene, T., Kimmel, P. L., Cushman, W. C., Hawfield, A. T., Johnson, K. C., Lewis, C. E., Oparil, S., Rocco, M. V., Sink, K. M., Whelton, P. K., Wright, Jr. J. T., Basile, J., Beddhu, S., Bhatt, U., Chang, T. I., Chertow, G. M., Chonchol, M., Freedman, B. I., Haley, W., Ix, J. H., Katz, L. A., Killeen, A. A., Papademetriou, V., Ricardo, A. C., Servilla, K., Wall, B., Wolfgram, D., Yee, J., and Sprint Research, Group. (2017) Effects of Intensive BP Control in CKD. Journal of the American Society of Nephrology 28, 2812-2823.","DOI":"10.1681\/ASN.201702014828642330https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28642330"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Coppolino, G., Bolignano, D., Campo, S., Loddo, S., Teti, D., and Buemi, M. (2008) Circulating progenitor cells after cold pressor test in hypertensive and uremic patients. Hypertension Research 31, 717-724.","DOI":"10.1291\/hypres.31.71718633184https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18633184"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Coppolino, G., Bolignano, D., Rivoli, L., Mazza, G., Presta, P., and Fuiano, G. (2014) Tumour markers and kidney function: a systematic review. BioMed Research International 2014, 1-9.","DOI":"10.1016\/j.urolonc.2017.03.02728427859https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28427859"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Coppolino, G., Leonardi, G., Andreucci, M., and Bolignano, D. (2018) Oxidative stress and kidney function: A brief update. Current Pharmaceutical Design 24, 4794-4799.","DOI":"10.2174\/138161282566619011216520630648504https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30648504"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Coppolino, G., Leporini, C., Rivoli, L., Ursini, F., di Paola, E. D., Cernaro, V., Arturi, F., Bolignano, D., Russo, E., De Sarro, G., and Andreucci, M. (2018) Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials. Pharmacol Research 129, 274-294.","DOI":"10.1016\/j.phrs.2017.12.00129223646https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29223646"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Coppolino, G., Pisano, A., Rivoli, L., and Bolignano, D. (2017) Renal denervation for resistant hypertension. Cochrane Database System Reviews 2, CD011499.","DOI":"10.1016\/j.pcad.2019.12.00731884099https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31884099"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., and Levey, A. S. (2007) Prevalence of chronic kidney disease in the United States. The Journal of the American Medical Association 298, 2038-2047.","DOI":"10.1001\/jama.298.17.203817986697https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17986697"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Cortes, P., Riser, B. L., Yee, J., and Narins, R. G. (1999) Mechanical strain of glomerular mesangial cells in the pathogenesis of glomerulosclerosis: clinical implications. Nephrology Dialysis Transplantation 14, 1351-1354.","DOI":"10.1093\/ndt\/14.6.135110382990https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10382990"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Damman, K., Tang, W. H., Testani, J. M., and McMurray, J. J. (2014) Terminology and definition of changes renal function in heart failure. European Heart Journal 35, 3413-3416.","DOI":"10.1093\/eurheartj\/ehu320251571104a9fdcf6-7f7f-44c5-9c09-522566b7b975https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25157110"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"De Nicola, L., Donfrancesco, C., Minutolo, R., Lo Noce, C., Palmieri, L., De Curtis, A., Iacoviello, L., Zoccali, C., Gesualdo, L., Conte, G., Vanuzzo, D., Giampaoli, S. and Anmco-Sin Research Group. (2015) Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey. Nephrology Dialysis Transplantation 30, 806-814.","DOI":"10.1093\/ndt\/gfu38325523453https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25523453"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"De Nicola, L., Minutolo, R., Chiodini, P., Borrelli, S., Zoccali, C., Postorino, M., Iodice, C., Nappi, F., Fuiano, G., Gallo, C., Conte, G. and C. K. D. Italian Society of Nephrology Study Group Target Blood pressure Levels in. (2012) The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. Kidney International 82, 482-488.","DOI":"10.1038\/ki.2012.17448864eed-5134-43da-b7d0-fcb1e19a821fhttp:\/\/dx.doi.org\/10.1038\/ki.2012.174"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"De Nicola, L., Minutolo, R., Chiodini, P., Zoccali, C., Castellino, P., Donadio, C., Strippoli, M., Casino, F., Giannattasio, M., Petrarulo, F., Virgilio, M., Laraia, E., Di Iorio, B. R., Savica, V., Conte, G. and Blood Pressure LEvels in Chronic Kidney Disease Study Group. (2006) Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney International 69, 538-545.","DOI":"10.1038\/sj.ki.500008516395261https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16395261"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"De Nicola, L., Provenzano, M., Chiodini, P., Borrelli, S., Garofalo, C., Pacilio, M., Liberti, M. E., Sagliocca, A., Conte, G. and Minutolo, R. and Sir-Sin study group. (2015) Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care. PLoS One 10, e0127071.","DOI":"10.1371\/journal.pone.012707125992629https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25992629"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"De Nicola, L., Provenzano, M., Chiodini, P., Borrelli, S., Russo, L., Bellasi, A., Santoro, D., Conte, G. and Minutolo, R. (2017) Epidemiology of low-proteinuric chronic kidney disease in renal clinics. PLoS One 12, e0172241.","DOI":"10.1371\/journal.pone.017224128212407https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28212407"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"De Nicola, L., Provenzano, M., Chiodini, P., D'Arrigo, G., Tripepi, G., Del Vecchio, L., Conte, G., Locatelli, F., Zoccali, C., Minutolo, R. and Sir-Sin study group. (2015) Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy. Nutrition, Metabolism & Cardiovascular Diseases 25, 756-762.","DOI":"10.1007\/s40519-019-00834-131900880https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31900880"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"De, Nicola L., and Zoccali, C. (2016) Chronic kidney disease prevalence in the general population: heterogeneity and concerns. Nephrology Dialysis Transplantation 31, 331-335.","DOI":"10.1093\/ndt\/gfv42726908831https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26908831"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"de Zeeuw, D., Remuzzi, G., Parving, H. H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E. and Brenner, B. M. (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110, 921-927.","DOI":"10.1161\/01.CIR.0000139860.33974.2815302780https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15302780"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., and Kofoed-Enevoldsen, A. (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32, 219-226.","DOI":"10.1007\/bf002852872668076https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2668076"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Ellam, T. J., El, Nahas M. (2011) Proteinuria thresholds are irrational: a call for proteinuria indexing. Nephron Clinical Practice 118, c217-c224.","DOI":"10.1159\/00032168721196766https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21196766"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Fox, C. S., Matsushita, K., Woodward, M., Bilo, H. J., Chalmers, J., Heerspink, H. J., Lee, B. J., Perkins, R. M., Rossing, P., Sairenchi, T., Tonelli, M., Vassalotti, J. A., Yamagishi, K., Coresh, J., de Jong, P. E., Wen, C. P., Nelson, R. G. and Consortium Chronic Kidney Disease Prognosis. (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. The Lancet 380, 1662-1673.","DOI":"10.1016\/S0140-6736(12)61350-623013602https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23013602"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Fuiano, G., Mancuso, D., Indolfi, C., Mongiardo, A., Sabbatini, M., Conte, G., De Nicola, L., Minutolo, R., Mazza, G., Cianfrone, P. and Andreucci, M. (2005) Early detection of progressive renal dysfunction in patients with coronary artery disease. Kidney International 68, 2773-2780.","DOI":"10.1111\/j.1523-1755.2005.00748.x16316352https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16316352"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Garofalo, C., Borrelli, S., Liberti, M. E., Andreucci, M., Conte, G., Minutolo, R., Provenzano, M. and De Nicola, L. (2019) SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects. Medicina (Kaunas) 55, 268.","DOI":"10.3390\/medicina5506026831212638https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31212638"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Goff, D. C. Jr., Lloyd-Jones, D. M., Bennett, G., Coady, S., D'Agostino, R. B. Sr., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O'Donnell, C. J., Robinson, J. G., Schwartz, J. S., Shero, S. T., Smith, S. C. Jr., Sorlie, P., Stone, N. J. and Wilson, P. W. F. (2014) 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 63, 2935-2959.","DOI":"10.1016\/j.jacc.2013.11.0052423992181df8b7f-9586-4943-b84c-3bf52605e858https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24239921"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Heerspink, H. J., Ninomiya, T., Perkovic, V., Woodward, M., Zoungas, S., Cass, A., Cooper, M., Grobbee, D. E., Mancia, G., Mogensen, C. E., Neal, B., Chalmers, J. and Advance Collaborative Group. (2010) Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. European Heart Journal 31, 2888-2896.","DOI":"10.1093\/eurheartj\/ehq13920501479https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20501479"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Kurella Tamura, M. and Feldman, H. I. (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. American Journal of Kidney Diseases 63, 713-735.","DOI":"10.1053\/j.ajkd.2014.01.416cd1d3c29-84d4-4521-8709-1d63afe92054http:\/\/dx.doi.org\/10.1053\/j.ajkd.2014.01.416"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W. and Striker, G. (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. The New England Journal of Medicine 330, 877-884.","DOI":"10.1056\/NEJM1994033133013018114857https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8114857"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Kluger, A. Y., Tecson, K. M., Lee, A. Y., Lerma, E. V., Rangaswami, J., Lepor, N. E., Cobble, M. E. and McCullough, P. A. (2019) Class effects of SGLT2 inhibitors on cardiorenal outcomes. Cardiovascular Diabetology 18, 99.","DOI":"10.1186\/s12933-019-0903-431382965https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31382965"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Kohan, D. E., and Barton, M. (2014) Endothelin and endothelin antagonists in chronic kidney disease. Kidney International 86, 896-904.","DOI":"10.1038\/ki.2014.1439e7ee383-a98a-4e77-8756-c81d31ad04cfhttp:\/\/dx.doi.org\/10.1038\/ki.2014.143"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Lash, J. P., Go, A. S., Appel, L. J., He, J., Ojo, A., Rahman, M., Townsend, R. R., Xie, D., Cifelli, D., Cohan, J., Fink, J. C., Fischer, M. J., Gadegbeku, C., Hamm, L. L., Kusek, J. W., Landis, J. R., Narva, A., Robinson, N., Teal, V., Feldman, H. I. and Group Chronic Renal Insufficiency Cohort Study. (2009) Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin Journal of the American Society of Nephrology 4, 1302-1311.","DOI":"10.2215\/CJN.1131111628751576https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28751576"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Levey, A. S. and Coresh, J. (2012) Chronic kidney disease. The Lancet 379, 165-180.","DOI":"10.1016\/S0140-6736(11)60178-521840587https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21840587"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Liang, S., Zhang, X. G., Cai, G. Y., Zhu, H. Y., Zhou, J. H., Wu, J., Chen, P., Lin, S. P., Qiu, Q. and Chen, X. M. (2013) Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis. PLoS One 8, e64184.","DOI":"10.1371\/journal.pone.006418423691167https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23691167"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Ljungman, S., Laragh, J. H. and Cody, R. J. (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 39, 10-21.","DOI":"10.2165\/00003495-199000394-000042354670https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2354670"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Mahmoodi, B. K., Matsushita, K., Woodward, M., Blankestijn, P. J., Cirillo, M., Ohkubo, T., Rossing, P., Sarnak, M. J., Stengel, B., Yamagishi, K., Yamashita, K., Zhang, L., Coresh, J., de Jong, P. E., Astor, B. C. and Consortium Chronic Kidney Disease Prognosis. (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. The Lancet 380, 1649-1661.","DOI":"10.1016\/S0140-6736(12)61272-023013600https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23013600"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Mann, J. F., Gerstein, H. C., Pogue, J., Bosch, J. and Yusuf, S. (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Annals of Internal Medicine 134, 629-636.","DOI":"10.7326\/0003-4819-134-8-200104170-0000711304102https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11304102"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Matsushita, K., Coresh, J., Sang, Y., Chalmers, J., Fox, C., Guallar, E., Jafar, T., Jassal, S. K., Landman, G. W., Muntner, P., Roderick, P., Sairenchi, T., Schottker, B., Shankar, A., Shlipak, M., Tonelli, M., Townend, J., van Zuilen, A., Yamagishi, K., Yamashita, K., Gansevoort, R., Sarnak, M., Warnock, D. G., Woodward, M., Arnlov, J. and C. K. D. Prognosis Consortium. (2015) Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. The Lancet Diabetes Endocrinol 3, 514-525.","DOI":"10.1016\/S2213-8587(15)00040-626028594https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26028594"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., Coresh, J., Gansevoort, R. T. and Chronic Kidney Disease Prognosis Consortium. (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. The Lancet 375, 2073-2081.","DOI":"10.1016\/S0140-6736(10)60674-520483451https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20483451"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"McCullough, P. A., Steigerwalt, S., Tolia, K., Chen, S. C., Li, S., Norris, K. C., Whaley-Connell, A. and Keep Investigators. (2011) Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Current Diabetes Reports 11, 47-55.","DOI":"10.1007\/s11892-010-0162-y8e720765-0fc2-4805-8f21-46cc34d09bb8http:\/\/link.springer.com\/article\/10.1007\/s11892-010-0162-y"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"McCullough, P. A., Whaley-Connell, A., Brown, W. W., Collins, A. J., Chen, S. C., Li, S., Norris, K. C., Jurkovitz, C., McFarlane, S., Obialo, C., Sowers, J., Stevens, L., Vassalotti, J. A., Bakris, G. L. and Investigators Kidney Early Evaluation Program. (2010) Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program. Internal Medicine Journal 40, 833-841.","DOI":"10.1111\/j.1445-5994.2009.02158.x21199222https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21199222"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"McIntyre, N. J. and Taal, M. W. (2008) How to measure proteinuria? Current Opinion in Nephrology and Hypertension 17, 600-603.","DOI":"10.1097\/MNH.0b013e328313675c18941353https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18941353"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Mensah, G. A., Wei, G. S., Sorlie, P. D., Fine, L. J., Rosenberg, Y., Kaufmann, P. G., Mussolino, M. E., Hsu, L. L., Addou, E., Engelgau, M. M. and Gordon, D. (2017) Decline in Cardiovascular Mortality: Possible Causes and Implications. Circulation Research 120, 366-380.","DOI":"10.1161\/CIRCRESAHA.116.30911528104770https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28104770"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Methven, S., MacGregor, M. S., Traynor, J. P., Hair, M., O'Reilly, D. S. and Deighan, C. J. (2011) Comparison of urinary albumin and urinary total protein as predictors of patient outcomes in CKD. American Journal of Kidney Diseases 57, 21-28.","DOI":"10.1053\/j.ajkd.2010.08.009b05e7cac-293b-4afa-a678-cfa7b093aa82http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0272638610012588"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J. and He, J. (2016) Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation 134, 441-450.","DOI":"10.1161\/CIRCULATIONAHA.115.01891227502908https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27502908"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Minutolo, R., Andreucci, M., Balletta, M. M. and Russo, D. (2000) Effect of posture on sodium excretion and diuretic efficacy in nephrotic patients. American Journal of Kidney Diseases 36, 719-727.","DOI":"10.1053\/ajkd.2000.1761611007673https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11007673"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Minutolo, R., De Nicola, L., Mazzaglia, G., Postorino, M., Cricelli, C., Mantovani, L. G., Conte, G. and Cianciaruso, B. (2008) Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy. American Journal of Kidney Diseases 52, 444-453.","DOI":"10.1053\/j.ajkd.2008.03.0028829a4f6-694d-4207-a0a1-8bbf89b653fehttp:\/\/www.sciencedirect.com\/science\/article\/pii\/S0272638608005763"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Minutolo, R., Gabbai, F. B., Provenzano, M., Chiodini, P., Borrelli, S., Garofalo, C., Sasso, F. C., Santoro, D., Bellizzi, V., Conte, G. and De Nicola, L. (2018) Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies. Nephrology Dialysis Transplantation 33, 1942-1949.","DOI":"10.1093\/ndt\/gfy03229509925https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29509925"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Murray, C. J. and Lopez, A. D. (2013) Measuring the global burden of disease. The New England Journal of Medicine 369, 448-457.","DOI":"10.1056\/NEJMra120153423902484https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23902484"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Nakano, T., Ninomiya, T., Sumiyoshi, S., Fujii, H., Doi, Y., Hirakata, H., Tsuruya, K., Iida, M., Kiyohara, Y. and Sueishi, K. (2010) Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study American Journal of Kidney Diseases 55, 21-30.","DOI":"10.1053\/S0272-6386(09)01471-119765871ceb7033d-75a3-4c2a-a9fc-06eebed92956https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19765871"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Neal, B., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Fulcher, G., Stein, P., Desai, M., Shaw, W., Jiang, J., Vercruysse, F., Meininger, G. and Matthews, D. (2013) Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial. American Heart Journal 166, 217-223 e11.","DOI":"10.1016\/j.ahj.2013.05.00765166eb8-9561-484a-a2ad-b5c8a1aadfe5http:\/\/dx.doi.org\/10.1016\/j.ahj.2013.05.007"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Ninomiya, T., Perkovic, V., de Galan, B. E., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., Mogensen, C. E., Cooper, M., Marre, M., Williams, B., Hamet, P., Mancia, G., Woodward, M., Macmahon, S., Chalmers, J. and Advance Collaborative Group. (2009) Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. Journal of the American Society of Nephrology 20, 1813-1821.","DOI":"10.1681\/ASN.200812127019443635https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19443635"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Norris, K., Bourgoigne, J., Gassman, J., Hebert, L., Middleton, J., Phillips, R. A., Randall, O., Rostand, S., Sherer, S., Toto, R. D., Wright, J. T. Jr., Wang, X., Greene, T., Appel, L. J., Lewis, J. and Aask Study Group. (2006) Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. American Journal of Kidney Diseases 48, 739-751.","DOI":"10.1053\/j.ajkd.2006.08.0043c302f56-7224-4483-b249-55f9c091212ahttp:\/\/www.sciencedirect.com\/science\/article\/pii\/S0272638606013035"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Ohtake, T., Kobayashi, S., Moriya, H., Negishi, K., Okamoto, K., Maesato, K. and Saito, S. (2005) High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. Journal of the American Society of Nephrology 16, 1141-1148.","DOI":"10.1681\/ASN.200409076515743997https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15743997"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Orth, S. R. and Hallan, S. I. (2008) Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients--absence of evidence or evidence of absence? Clin Journal of the American Society of Nephrology 3, 226-236.","DOI":"10.1038\/s41467-019-13823-w31900412https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31900412"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Parving, H. H., Brenner, B. M., McMurray, J. J., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., Richard, A., Xiang, Z., Brunel, P., Pfeffer, M. A. and Altitude Investigators. (2012) Cardiorenal end points in a trial of aliskiren for type 2 diabetes. The New England Journal of Medicine 367, 2204-2213.","DOI":"10.1056\/NEJMoa120879923121378https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23121378"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., Cannon, C. P., Capuano, G., Chu, P. L., de Zeeuw, D., Greene, T., Levin, A., Pollock, C., Wheeler, D. C., Yavin, Y., Zhang, H., Zinman, B., Meininger, G., Brenner, B. M., Mahaffey, K. W. and Credence Trial, Investigators. (2019) Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. The New England Journal of Medicine 380, 2295-2306.","DOI":"10.1056\/NEJMoa181174430990260https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30990260"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Perkovic, V., Ninomiya, T., Arima, H., Gallagher, M., Jardine, M., Cass, A., Neal, B., Macmahon, S. and Chalmers, J. (2007) Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study. Journal of the American Society of Nephrology 18, 2766-2772.","DOI":"10.1681\/ASN.200702025617804673https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17804673"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Perticone, F., Perticone, M., Maio, R., Sciacqua, A., Andreucci, M., Tripepi, G., Corrao, S., Mallamaci, F., Sesti, G. and Zoccali, C. (2015) Serum alkaline phosphatase negatively affects endothelium-dependent vasodilation in naive hypertensive patients. Hypertension 66, 874-880.","DOI":"10.1161\/HYPERTENSIONAHA.115.0611726324506https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26324506"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Perticone, M., Maio, R., Sciacqua, A., Cimellaro, A., Andreucci, M., Tripepi, G., Zoccali, C., Sesti, G. and Perticone, F. (2016) Serum phosphorus levels are associated with endothelial dysfunction in hypertensive patients. Nutrition, Metabolism & Cardiovascular Diseases 26, 683-688.","DOI":"10.1007\/s40519-019-00834-131900880https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31900880"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Petrykiv, S. I., de Zeeuw, D., Persson, F., Rossing, P., Gansevoort, R. T., Laverman, G. D. and Heerspink, H. J. L. (2017) Variability in response to albuminuria-lowering drugs: true or random? British Journal of Clinical Pharmacology 83, 1197-1204.","DOI":"10.1111\/bcp.1321728002889https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28002889"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corra, U., Cosyns, B., Deaton, C., Graham, I., Hall, M. S., Hobbs, F. D. R., Lochen, M. L., Lollgen, H., Marques-Vidal, P., Perk, J., Prescott, E., Redon, J., Richter, D. J., Sattar, N., Smulders, Y., Tiberi, M., van der Worp, H. B., van Dis, I., Verschuren, W. M. M., Binno, S. and E. S. C. Scientific Document Group. (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal 37, 2315-2381.","DOI":"10.1093\/eurheartj\/ehw10627222591https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27222591"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., Gonzalez-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M. C., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., van der Meer, P. and E. S. C. Scientific Document Group. (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal 37, 2129-2200.","DOI":"10.1093\/eurheartj\/ehw12827206819https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27206819"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Provenzano, M., Chiodini, P., Minutolo, R., Zoccali, C., Bellizzi, V., Conte, G., Locatelli, F., Tripepi, G., Del Vecchio, L., Mallamaci, F., Di Micco, L., Russo, D., Heerspink, H. J. L., De Nicola, L. and C. K. D. of the Italian Society of Nephrology Collaborative Study Group on the Conservative Treatment of. (2018) Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics. Nephrology Dialysis Transplantation 2018, 1-9.","DOI":"10.1093\/ndt\/gfy21730053127https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30053127"},{"key":"ref76","unstructured":"Provenzano, M., Mancuso, C., Garofalo, C., De Nicola, L. and Andreucci, M. (2019) [Temporal variation of Chronic Kidney Disease's epidemiology]. Giornale italiano di nefrologia 36, pii: 2019-vol2. 31830398https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31830398"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Rahman, M., Pressel, S., Davis, B. R., Nwachuku, C., Wright, J. T Jr., Whelton, P. K., Barzilay, J., Batuman, V., Eckfeldt, J. H., Farber, M. A., Franklin, S., Henriquez, M., Kopyt, N., Louis, G. T., Saklayen, M., Stanford, C., Walworth, C., Ward, H., Wiegmann, T. and Allhat Collaborative Research Group. (2006) Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Annals of Internal Medicine 144, 172-180.","DOI":"10.7326\/0003-4819-144-3-200602070-0000516461961https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16461961"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Rangaswami, J., Bhalla, V., Blair, J. E. A., Chang, T. I., Costa, S., Lentine, K. L., Lerma, E. V., Mezue, K., Molitch, M., Mullens, W., Ronco, C., Tang, W. H. W., McCullough, P. A., Disease American Heart Association Council on the Kidney in Cardiovascular, and Cardiology Council on Clinical. (2019) Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation 139, e840-e878.","DOI":"10.1161\/CIR.000000000000066430852913https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30852913"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Remuzzi, A., Gagliardini, E., Sangalli, F., Bonomelli, M., Piccinelli, M., Benigni, A. and Remuzzi, G. (2006) ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney International 69, 1124-1130.","DOI":"10.1038\/sj.ki.500006016395266https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16395266"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Remuzzi, A., Perticucci, E., Ruggenenti, P., Mosconi, L., Limonta, M. and Remuzzi, G. (1991) Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney International 39, 1267-1273.","DOI":"10.1038\/ki.1991.1601716713https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1716713"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Ronco, C., McCullough, P., Anker, S. D., Anand, I., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., Daliento, L., Davenport, A., Haapio, M., Hillege, H., House, A. A., Katz, N., Maisel, A., Mankad, S., Zanco, P., Mebazaa, A., Palazzuoli, A., Ronco, F., Shaw, A., Sheinfeld, G., Soni, S., Vescovo, G., Zamperetti, N., Ponikowski, P. and group Acute Dialysis Quality Initiative consensus. (2010) Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. European Heart Journal 31, 703-711.","DOI":"10.1093\/eurheartj\/ehp50720037146https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20037146"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Russo, D., Andreucci, M., De Blasio, A., Frattolillo, P. and Andreucci, V. E. (2005) Treatment of hypertension in Italian nephrology out-patient clinics: the THIN Study. Seminars in Nephrology 25, 431-434.","DOI":"10.1016\/j.semnephrol.2005.05.01516298268https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16298268"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Russo, D., Corrao, S., Battaglia, Y., Andreucci, M., Caiazza, A., Carlomagno, A., Lamberti, M., Pezone, N., Pota, A., Russo, L., Sacco, M. and Scognamiglio, B. (2011) Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney International 80, 112-118.","DOI":"10.1038\/ki.2011.699bc31209-cb87-46d4-b632-22b71cd08ce3http:\/\/dx.doi.org\/10.1038\/ki.2011.69"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Sarafidis, P. A., Khosla, N. and Bakris, G. L. (2007) Antihypertensive therapy in the presence of proteinuria. American Journal of Kidney Diseases 49, 12-26.","DOI":"10.1053\/j.ajkd.2006.10.01425281ae6-ce77-4aef-92ee-24d595f25ab8http:\/\/www.sciencedirect.com\/science\/article\/pii\/S027263860601612X"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Savarese, G., Dei Cas, A., Rosano, G., D'Amore, C., Musella, F., Mosca, S., Reiner, M. F., Marchioli, R., Trimarco, B. and Perrone-Filardi, P. (2014) Reduction of albumin urinary excretion is associated with reduced cardiovascular events in hypertensive and\/or diabetic patients. A meta-regression analysis of 32 randomized trials. International Journal of Cardiology 172, 403-410.","DOI":"10.1016\/j.ijcard.2014.01.065cc2b1d57-722c-43fc-9001-44acc68bc28bhttp:\/\/dx.doi.org\/10.1016\/j.ijcard.2014.01.065"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Shiga, T., Kasanuki, H., Hagiwara, N., Sumiyoshi, T., Honda, T., Haze, K., Takagi, A., Kawana, M., Origasa, H., Ogawa, H. and Investigators Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease. (2010) Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function. Blood Pressure 19, 359-365.","DOI":"10.3109\/0803705100380247520491606https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20491606"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Solomon, S. D., Rice, M. M., Jablonski K, A., Jose, P., Domanski, M., Sabatine, M., Gersh, B. J., Rouleau, J., Pfeffer, M. A., Braunwald, E. and A. C. E. inhibition Investigators Prevention of Events with. (2006) Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation 114, 26-31.","DOI":"10.1161\/CIRCULATIONAHA.105.59273316801465https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16801465"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Stehouwer, C. D., Nauta, J. J., Zeldenrust, G. C., Hackeng, W. H., Donker, A. J. and den Ottolander, G. J. (1992) Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. The Lancet 340, 319-323.","DOI":"10.1111\/joim.1212823981104https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23981104"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":", Stevens, P. E., Levin, A and Members Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group. (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of Internal Medicine 158, 825-830.","DOI":"10.7326\/0003-4819-158-11-201306040-00007c23cd14f-47fb-4854-8441-2386a3a3ac9dhttp:\/\/dx.doi.org\/10.7326\/0003-4819-158-11-201306040-00007"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Tonelli, M., Muntner, P., Lloyd, A., Manns, B. J., Klarenbach, S., Pannu, N., James, M. T., Hemmelgarn, B. R. and Network Alberta Kidney Disease. (2012) Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. The Lancet 380, 807-814.","DOI":"10.1016\/S0140-6736(12)60572-822717317https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22717317"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., Zinman, B. and Empa-Reg Outcome Investigators. (2016) Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. The New England Journal of Medicine 375, 323-334.","DOI":"10.1056\/NEJMoa151592027299675https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27299675"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Weiner, D. E., Tighiouart, H., Elsayed, E. F., Griffith, J. L., Salem, D. N., Levey, A. S. and Sarnak, M. J. (2007) The Framingham predictive instrument in chronic kidney disease. Journal of the American College of Cardiology 50, 217-224.","DOI":"10.1016\/j.jacc.2007.03.037b190074f-bbf4-45bf-be80-cfa778a8ab22http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0735109707013484"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Whaley-Connell, A., Kurella, M. and McCullough, P. A. (2012) A decade after the KDOQI CKD guidelines: impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP). American Journal of Kidney Diseases 60, 692-693.","DOI":"10.1053\/j.ajkd.2012.08.008230676314aa1c988-b539-47ed-91d2-12d751bffc75https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23067631"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Whaley-Connell, A. T., Kurella Tamura, M., Jurkovitz, C. T., Kosiborod, M. and McCullough, P. A. (2013) Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report. American Journal of Kidney Diseases 61, S1-S3.","DOI":"10.1053\/j.ajkd.2013.01.00623507265db736512-c9f6-4e85-98f7-0f2c535b254ehttps:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23507265"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., Ruff, C. T., Gause-Nilsson, I. A. M., Fredriksson, M., Johansson, P. A., Langkilde, A. M., Sabatine, M. S. and Declare-Timi Investigators. (2019) Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. The New England Journal of Medicine 380, 347-357.","DOI":"10.1056\/NEJMoa181238930415602https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30415602"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Xia, J., Wang, L., Ma, Z., Zhong, L., Wang, Y., Gao, Y., He, L. and Su, X. (2017) Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrology Dialysis Transplantation 32, 475-487.","DOI":"10.1093\/ndt\/gfw45228339863https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28339863"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Xie, Y., Bowe, B., Mokdad, A. H., Xian, H., Yan, Y., Li, T., Maddukuri, G., Tsai, C. Y., Floyd, T. and Al-Aly, Z. (2018) Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney International 94, 567-581.","DOI":"10.1016\/j.kint.2018.04.01130078514https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30078514"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Zelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Furtado, R. H. M., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H. and Sabatine, M. S. (2019) SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. The Lancet 393, 31-39.","DOI":"10.1016\/S0140-6736(18)32590-X30424892https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30424892"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Zhang, L., Wang, F., Wang, L., Wang, W., Liu, B., Liu, J., Chen, M., He, Q., Liao, Y., Yu, X., Chen, N., Zhang, J. E., Hu, Z., Liu, F., Hong, D., Ma, L., Liu, H., Zhou, X., Chen, J., Pan, L., Chen, W., Wang, W., Li, X. and Wang, H. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. The Lancet 379, 815-822.","DOI":"10.1016\/S0140-6736(12)60033-622386035https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22386035"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M. J., Ali, M. K., Taddei, C. and NCD Risk Factor Collaboration (NCD-RisC). (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. The Lancet 387, 1513-1530.","DOI":"10.1016\/S0140-6736(16)00618-827061677https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27061677"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Zoccali, C., Blankestijn, P. J., Bruchfeld, A., Capasso, G., Fliser, D., Fouque, D., Goumenos, D., Ketteler, M., Massy, Z., Rychlik, I., Jose Soler, M., Stevens, K., Spasovski, G. and Wanner, C. (2019) Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials. Nephrology Dialysis Transplantation 34, 1112-1114.","DOI":"10.1093\/ndt\/gfz07030977814https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30977814"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/20\/4\/10.31083\/j.rcm.2019.04.548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T16:53:24Z","timestamp":1732726404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/20\/4\/10.31083\/j.rcm.2019.04.548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,30]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["2153-8174-20-4-209"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm.2019.04.548","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,30]]},"article-number":"209"}}